Drug profile · INN
eptacog beta (activated)
CEVENFACTA
eptacog beta (activated) (CEVENFACTA) is a coagulation factor vii exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02BD08
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — eptacog beta (activated)
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
eptacog beta (activated) (CEVENFACTA) is a coagulation factor vii exogenous protein.
Key facts
INN eptacog beta (activated)
Brand CEVENFACTA
Mechanism Coagulation factor VII exogenous protein
Target Coagulation factor VII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD08
Mechanism of action
Coagulation factor VII exogenous protein
Primary target: Coagulation factor VII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is eptacog beta (activated)?
eptacog beta (activated) (CEVENFACTA) is a coagulation factor vii exogenous protein.
What is the brand name for eptacog beta (activated)?
CEVENFACTA is a marketed brand name for eptacog beta (activated). Check FDA Drugs@FDA for the current US label holder and prescribing information.